Aspira Women's Health Faces Delisting Notice

Ticker: AWHL · Form: 8-K · Filed: 2025-02-14T00:00:00.000Z

Sentiment: bearish

Topics: delisting, listing-standards, compliance

TL;DR

Aspira Women's Health got a notice about possibly being delisted. Big trouble ahead?

AI Summary

Aspira Women's Health Inc. filed an 8-K on February 14, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard as of February 11, 2025. The company, formerly known as Vermillion, Inc., Ciphergen Biosystems Inc., and Abiotic Systems, is incorporated in Delaware and headquartered in Austin, Texas.

Why It Matters

This filing indicates potential delisting from a stock exchange, which could significantly impact the company's liquidity and investor confidence.

Risk Assessment

Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's continued trading and investor confidence.

Key Players & Entities

Aspira Women's Health Inc. (company) — Registrant
February 11, 2025 (date) — Date of earliest event reported
February 14, 2025 (date) — Date of report
Vermillion, Inc. (company) — Former company name
Ciphergen Biosystems Inc (company) — Former company name
Abiotic Systems (company) — Former company name
Delaware (jurisdiction) — State of incorporation
Austin, Texas (location) — Business address city and state

FAQ

What specific listing rule or standard has Aspira Women's Health Inc. failed to satisfy?

The filing states that the company received a notice of delisting or failure to satisfy a continued listing rule or standard, but does not specify which rule or standard was violated.

What is the date of the notice of delisting or failure to satisfy a continued listing rule?

The earliest event reported, which includes the notice, is dated February 11, 2025.

When was this Form 8-K filed with the SEC?

This Form 8-K was filed on February 14, 2025.

What were some of Aspira Women's Health Inc.'s former company names?

Aspira Women's Health Inc. was formerly known as Vermillion, Inc., Ciphergen Biosystems Inc, and Abiotic Systems.

Where is Aspira Women's Health Inc. incorporated and headquartered?

The company is incorporated in Delaware and its business address is in Austin, Texas.

From the Filing

0001493152-25-006890.txt : 20250214 0001493152-25-006890.hdr.sgml : 20250214 20250214163026 ACCESSION NUMBER: 0001493152-25-006890 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20250211 ITEM INFORMATION: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing FILED AS OF DATE: 20250214 DATE AS OF CHANGE: 20250214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aspira Women's Health Inc. CENTRAL INDEX KEY: 0000926617 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 330595156 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-34810 FILM NUMBER: 25629658 BUSINESS ADDRESS: STREET 1: 12117 BEE CAVES ROAD BUILDING THREE STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78738 BUSINESS PHONE: 512-519-0400 MAIL ADDRESS: STREET 1: 12117 BEE CAVES ROAD BUILDING THREE STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78738 FORMER COMPANY: FORMER CONFORMED NAME: VERMILLION, INC. DATE OF NAME CHANGE: 20070824 FORMER COMPANY: FORMER CONFORMED NAME: CIPHERGEN BIOSYSTEMS INC DATE OF NAME CHANGE: 20000316 FORMER COMPANY: FORMER CONFORMED NAME: ABIOTIC SYSTEMS DATE OF NAME CHANGE: 19950407 8-K 1 form8-k.htm false 0000926617 0000926617 2025-02-11 2025-02-11 iso4217:USD xbrli:shares iso4217:USD xbrli:shares       UNITED STATES   SECURITIES AND EXCHANGE COMMISSION   Washington, D.C. 20549       Form 8-K     CURRENT REPORT   Pursuant to Section 13 or 15(d) of   The Securities Exchange Act of 1934   Date of Report (Date of earliest event reported): February 11, 2025     Aspira Women’s Health Inc.   (Exact name of registrant as specified in its charter)     Delaware   001-34810   33-0595156 (State or other jurisdiction   (Commission   (IRS Employer of incorporation)   File Number)   Identification No.)   12117 Bee Caves Road , Building III , Suite 100 , Austin , Texas   78738 (Address of principal executive offices)   (Zip Code)   Registrant’s telephone number, including area code: (512) 519-0400       Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common Stock, par value $0.001 per share   AWH   Nasdaq Capital Market    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐             Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing .   On June 30, 2024, Aspira Women’s Health Inc. (the “Company”) entered into a securities pur